Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.02
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.02. Revenue for the quarter came in at $10.08 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
